| Encyclopaedia |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Stocks Mutual Funds > Six Things To Do In A High Risk Market |
|
Encyclopaedia - Six Things To Do In A High Risk Market
When the market turns against you, what should you do? Sell everything? We discussed that choice in a recent column. Selling everything draws your “line in th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e sand” and announces that you have determined there is no future for you in the market. There are other steps you can take when things start moving against you ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in . Here are 6 actions you take today to help protect the money you’ve worked hard to get. In my next article, I will share several more ways you can help protec lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t your stock market and mutual fund investments. 1. Decide at what price you will buy the stock or fund if it pulls back. Take a long look at where the stock h here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe as been the last few months. Has it gone up without any kind of break? It may be due for a pullback. WRITE DOWN your reasons for buying and the ideal price yo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro u’d like to own it at...and be patient. If you miss it, you miss it. Don’t chase stocks. 2. Manage your stops. Re-examine where your stop orders are and dec ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ide if you can live with getting stopped out. These days, stop orders usually need to be renewed or revised every 60 days. If your stock has moved up nicely of easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi late, you should move your stop up as well. 3. Buy puts on stocks. You may own a stock where you have a profit. You may really have no intention of selling t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically he stock soon. But you know that the individual stock may have gone up too far, too fast. Buy a put on the position. It is considered protection on your origi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nal investment. If the stock falls, the puts should climb in value. This will offset the drop you have (on paper) in the underlying stock. And if you’re right ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi , and take a profit in the put, you may have enough cash from the put sale to buy more shares of that stock at a good price, now that it has dropped. 4. Buy hal ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a f of what you would normally buy. You want to tread lightly in markets when the risk is high. Buy half of what you’d normally think of doing. You‘re automatic dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ally keeping more cash than usual on the sidelines, which is smart decision in a risky market. 5. Invest in a basket instead of an individual stock. Exchange-t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin raded funds are a great way to do this. If you feel strongly that a current theme will work, but are unsure about the market, this may be your ticket. Thinking tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen about swapping a single stock for a basket. You’ll get diversified since you own a basket of names instead of one single stock. 6. When stocks start to fall, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel think about selling stocks short. It’s not for the faint of heart, since being “short” leaves you on the hook, because your loss is unlimited. But remember, st ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ocks don’t just go in one direction. What makes it an interesting market is that stocks go up AND down. One decision you won’t see on the list is the choice to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products do nothing, and just “sit it out” or ride it out. You’ve worked hard to get where you are financially, the last thing you should do is sit idle and let the mar . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ket take your profits away from you. There are other methods you can employ to help reduce the risk in your account, which we will get into in the next article. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip In the meantime, feel free to contact us, toll-free, at 877-223-7300 if you would like further information on how to protect your assets in a high risk market. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Complaints? Cut 'm Off At The Pass Pardner Want To Join the Bandwagon? Be Sure It Has Wheels!
|